4D Molecular Therapeutics, Inc. (FDMT) Revenue Growth
4D Molecular Therapeutics, Inc. (FDMT) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | 32.52% |
| 2022-12-31 | -82.65% |
| 2023-12-31 | 562.29% |
| 2024-12-31 | -99.82% |
| 2025-12-31 | 230194.59% |
How FDMT compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| IDYA | IDEAYA Biosciences Inc. | 3024.43% |
| HSDT | Helius Medical Technologies Inc. | 1057.12% |
| SNDX | Syndax Pharmaceuticals Inc. | 627.84% |
| ETON | Eton Pharmaceuticals Inc. | 104.94% |
| TGTX | TG Therapeutics Inc. | 87.32% |
These are five companies in the same sector as FDMT with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get 4D Molecular Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("FDMT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | FDMT | $14.11 | -3.82% | 1.40M |
| 3 | ||||
| 4 | ||||
| 5 |